Bisphosphonates Linked With Lower Death Risk After Low-Trauma Break

(Medage today) – Seattle – The risk of death was lower in the years that followed a bisphosphonate after a fracture rather than denosumab (Polia), revealed target trial emulation. In adults aged 50 and over who have experienced weak trauma …